Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetRevenue - OtherRevenue - RentalShares Issued
Ratios

Maxcyte (MXCT) Shares Issued (2021 - 2025)

Maxcyte (MXCT) has disclosed Shares Issued for 5 consecutive years, with $15000.0 as the latest value for Q4 2025.

  • Quarterly Shares Issued fell 92.27% to $15000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $432000.0 through Dec 2025, down 5.88% year-over-year, with the annual reading at $432000.0 for FY2025, 5.88% down from the prior year.
  • Shares Issued for Q4 2025 was $15000.0 at Maxcyte, up from $14000.0 in the prior quarter.
  • The five-year high for Shares Issued was $181.8 million in Q4 2021, with the low at -$1.4 million in Q4 2023.
  • Average Shares Issued over 5 years is $14.0 million, with a median of $325500.0 recorded in 2022.
  • Peak annual rise in Shares Issued hit 114.05% in 2024, while the deepest fall reached 378.98% in 2024.
  • Over 5 years, Shares Issued stood at $181.8 million in 2021, then crashed by 99.33% to $1.2 million in 2022, then plummeted by 212.69% to -$1.4 million in 2023, then surged by 114.05% to $194000.0 in 2024, then crashed by 92.27% to $15000.0 in 2025.
  • According to Business Quant data, Shares Issued over the past three periods came in at $15000.0, $14000.0, and $20000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.